Facilitators and barriers to medication adherence among stroke survivors in India

被引:11
|
作者
Shani, S. D. [1 ]
Sylaja, P. N. [2 ]
Sarma, P. Sankara [1 ]
Kutty, V. Raman [3 ]
机构
[1] Sree Chitra Tirunal Inst Med Sci & Technol SCTIMS, Achutha Menon Ctr Hlth Sci Studies AMCHSS, Thiruvananthapuram, Kerala, India
[2] Sree Chitra Tirunal Inst Med Sci & Technol SCTIMS, Dept Neurol, Thiruvananthapuram 695011, Kerala, India
[3] Amala Canc Res Ctr, Trichur 680555, India
关键词
Medication adherence; Risk factor control; Stroke survivors; Life style; India; SECONDARY PREVENTION; ISCHEMIC-STROKE; RISK;
D O I
10.1016/j.jocn.2021.03.019
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Strict compliance with medication and life style modification are integral to secondary stroke prevention. This study was undertaken to find out medication adherence among stroke survivors and factors associated with it. Cross sectional survey among stroke survivors was conducted. Interview based self-reported medication adherence was defined as consumption at least >80% of their medications for last two weeks, based on last prescription. Structured interview using pretested interview schedule was done to collect other data. Sequential step wise logistic regression analysis was done to find out the facilitators and barriers to medication adherence. Two hundred and forty stroke survivors (mean age 58.64 +/- 10.96 years; 25.4% females) with a mean post-stroke period of 6.65 +/- 3.36 months were participated. Overall medication adherence was 43.8% (n = 105). Medication adherence was 34.3% (n = 134), 52.6% (n = 190) and 56.7% (n = 224) for antidiabetics, antihypertensives and statins respectively and was associated with risk factor control (Diabetes: Odds Ratio (OR) = 4.85; 95% Confidence Interval (CI) 2.12-11.08, Hypertension: OR = 3.42; 95% CI 1.83-6.4, Dyslipidaemia: OR = 3.88; 95% CI 1.96-4.04). Having daily routine (OR = 2.82; 95% CI 1.52-5.25), perceived need of medication (OR = 2.33; 95% CI 1.04-5.2) and perceived poor state of health (OR = 2.65; 95% CI 1.30-5.40) were facilitators. Memory issues (OR = 0.34; 95% CI 0.16-0.71), side effects (OR = 0.24; 95% CI 0.11-0.42) and financial constraints (OR = 0.46; 95% CI 0.24-0.91) were barriers to medication adherence. Establishing daily routines, periodic reminders, financial supports to buy medicines and patient education can enhance medication adherence to prevent future strokes. (c) 2021 Elsevier Ltd. All rights reserved.
引用
收藏
页码:185 / 190
页数:6
相关论文
共 50 条
  • [1] Facilitators and Barriers to Medication Adherence Among Stroke Survivors in India
    Shani, S. D.
    Kutty, V. R.
    Varma, R. P.
    Jissa, V. T.
    Sylaja, P. N.
    STROKE, 2020, 51
  • [2] Barriers and facilitators to exercise among stroke survivors
    Damush, Teresa M.
    Plue, Laurie
    Bakas, Tamilyn
    Schmid, Arlene
    Williams, Linda S.
    REHABILITATION NURSING, 2007, 32 (06) : 253 - +
  • [3] Barriers to and Facilitators of Medication Adherence
    Rolnick, Sharon J.
    Asche, Steve
    Pawloski, Pamala A.
    Bruzek, Richard J.
    Hedblom, Brita
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2013, 5 (05) : 209 - 215
  • [4] Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: A qualitative study
    Kumarasamy, N
    Safren, SA
    Raminani, SR
    Pickard, R
    James, R
    Krishnan, AKS
    Solomon, S
    Mayer, KH
    AIDS PATIENT CARE AND STDS, 2005, 19 (08) : 526 - 537
  • [5] Facilitators and Barriers to Glaucoma Medication Adherence
    Gatwood, Justin
    Brooks, Callee
    Meacham, Ryan
    Abou-Rahma, Joseph
    Cernasev, Alina
    Brown, Eric
    Kuchtey, Rachel W.
    JOURNAL OF GLAUCOMA, 2022, 31 (01) : 31 - 36
  • [6] Facilitators & barriers of medication adherence among the geriatric: A developing country scenario
    Harsha, Chalasani Sri
    Madhan, Ramesh
    Pereira, Prathibha
    Thomas, Anmaria
    Stephen, Steby Mol
    Dharvees, Mohamed T.
    Crasta, Sandy D.
    Syed, Jehath M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 520 - 521
  • [7] Medication Adherence in Pediatric MS: Barriers and Facilitators
    Grover, Stephanie
    Edwards, Kim
    Alper, Gulay
    Banwell, Brenda
    Breiner, Petra
    Gorman, Mark
    Graves, Jennifer
    Hart, Janace
    Lotze, Timothy
    Mar, Soe
    Mednick, Lauren
    Ness, Jayne
    Noguera, Austin
    Quon, Elizabeth
    Schreiner, Teri
    Schwartz, Carolyn
    Waldman, Amy
    Waubant, Emmanuelle
    Slater, Ruth
    Yeh, E. Ann
    NEUROLOGY, 2016, 86
  • [8] Adherence to medication: Patient reported facilitators and barriers
    Ramesh, Madhan
    Kumar, Abaka Mohith
    Majeed, Fasil P., V
    Rejimon, Patric
    Chinemerem, Emelda
    Harsha, Chalasani Sri
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 134 - 134
  • [9] Barriers and Facilitators to Engagement in Rehabilitation Among Stroke Survivors An Integrative Review
    Forgea, Mary C.
    Lyons, Amy G.
    Lorenz, Rebecca A.
    REHABILITATION NURSING, 2021, 46 (06) : 340 - 347
  • [10] Identifying and Understanding Barriers and Facilitators to Medication Adherence Among Marshallese Adults in Arkansas
    McElfish, Pearl A.
    Balli, Michelle L.
    Hudson, Jonell S.
    Long, Christopher R.
    Hudson, Teresa
    Wilmoth, Ralph
    Rowland, Brett
    Warmack, T. Scott
    Purvis, Rachel S.
    Schulz, Thomas
    Riklon, Sheldon
    Holland, Angel
    Dickey, Tiffany
    JOURNAL OF PHARMACY TECHNOLOGY, 2018, 34 (05) : 204 - 215